VEGFA and neoplasm: Through genetic engineering, probiotics can be tailored to express anti‐tumour molecules; for example, Bifidobacterium infantis expressing soluble fms‐like tyrosine kinase receptor (sFlt‐1), a tyrosine kinase with antiangiogenic properties, effectively suppresses vascular endothelial growth factor (VEGF)‐induced cell proliferation, consequently impeding tumour growth and extending survival in mice murine models (Zhu et al. 2011).